TL;DR: Sixfold Bioscience is a Y Combinator Winter 2018 startup Delivering RNA therapies., currently active with a team of 27.
Delivering RNA therapies.
Last verified:
Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.
Built by LemStudio
Yes. Sixfold Bioscience was funded by Y Combinator in the Winter 2018 batch. Delivering RNA therapies.
Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.
Sixfold Bioscience was part of Y Combinator's Winter 2018 batch.
Sixfold Bioscience has a team of 27 people according to Y Combinator's directory.
Sixfold Bioscience is currently listed as Active with a team of 27 in Y Combinator's directory.
Loading interactive view…